Patient considerations in early management of Parkinson’s disease: focus on extended-release pramipexole
Fatai Kunle SalawuDivision of Neurology, Department of Medicine, Federal Medical Centre Yola, Adamawa State, NigeriaAbstract: This article reviews the role of an extended-release formulation of pramipexole in the treatment of Parkinson’s disease at an early stage. Pramipexole is a none...
Main Author: | Salawu FK |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-01-01
|
Series: | Patient Preference and Adherence |
Online Access: | http://www.dovepress.com/patient-considerations-in-early-management-of-parkinsonrsquos-disease--a9061 |
Similar Items
-
Update on the use of pramipexole in the treatment of Parkinson’s disease
by: Radu Constantinescu
Published: (2008-04-01) -
Pharmacoeconomic evaluation of pramipexole extended release monotherapy in early Parkinson’s disease
by: D. Yu. Belousov, et al.
Published: (2018-05-01) -
Pramipexole and its Extended Release Formulation for Parkinson’s Disease
by: Paul S. Fishman
Published: (2011-06-01) -
Pramipexole and its Extended Release Formulation for Parkinson's Disease
by: Paul S. Fishman
Published: (2011-01-01) -
Beneficial effect of pramipexole for motor function and depression in Parkinson’s disease
by: Osamu Kano, et al.
Published: (2009-02-01)